Silo Pharma, Inc. SILO
1.75
0.00
0.00%
as of 25 Sep
- Market cap
- $2.8M
- P/E
- 0.0×
Follow SILO
Insider Buys
alert about insiders buying in the last 12 month
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | — | — | 0.00 | — | 3.48 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.00 | — | — | 0.00 | — | 190.70 | 97.47 | 65.04 | 45.52 | 39.60 |
P/FCF ratio |
0.00 | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | — | — | (1,403.41) | — | (17.54) | (7.92) | (5.15) | (3.57) | (3.65) |
P/B ratio |
0.00 | — | — | 0.00 | — | 1.50 | 0.68 | 0.76 | 0.65 | 0.45 |
Price to Tangible BV |
0.00 | — | — | 0.00 | — | 1.50 | 0.68 | 0.76 | 0.68 | 0.47 |
EV/Sales |
0.00 | — | — | 0.00 | — | 46.69 | (60.40) | (41.37) | (52.77) | (55.61) |
EV/EBITDA |
0.00 | — | — | 0.00 | — | 0.00 | 1.20 | 0.79 | 0.81 | 0.94 |
EV/Operating CF |
0.00 | — | — | (517.26) | — | (1.46) | 1.24 | 0.92 | 0.99 | 0.86 |
EV/FCF |
0.00 | — | — | (517.26) | — | (1.46) | 1.24 | 0.92 | 0.99 | 0.86 |
Quick Ratio |
23.97 | 42.16 | 11.77 | 2.75 | 8.13 | 20.93 | 26.21 | 9.88 | 4.28 | 10.55 |
Current Ratio |
24.47 | 42.86 | 13.04 | 4.23 | 10.07 | 21.23 | 26.52 | 9.90 | 4.29 | 11.36 |
Net Debt/EBITDA |
3.08 | 3.29 | 0.94 | 0.07 | 0.82 | 3.89 | 3.13 | 2.04 | 1.51 | 1.61 |
Debt/Assets |
0.00% | 0.00% | 2.61% | 12.54% | 1.32% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.05 | (2.70) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.08 | 0.00 | 0.00 | 0.06 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Operating CF/Net income |
0.13 | (0.80) | (0.28) | 0.78 | 0.37 | (0.91) | 0.89 | 0.87 | 0.87 | 1.10 |
Capex/Depreciation |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | (50.43) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 34.79% | (120.40%) | (527.07%) | (493.96%) | 48.34% | (40.29%) | (44.81%) | (78.37%) | (74.56%) | |
| (171.28%) | 24.24% | (77.66%) | (150.21%) | (323.51%) | 41.95% | (35.32%) | (38.17%) | (57.96%) | (56.31%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (804.71%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(89.29%) | 22.24% | (167.73%) | (268.71%) | (241.75%) | 25.22% | (35.10%) | (53.59%) | (80.52%) | (62.75%) |
Average Days of Receivables |
428.77 | — | — | 1,798.03 | 0.00 | 0.00 | 334.12 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | — | — | 156.40% | 0.00% | 973.21% | 1,784.19% | 1,172.12% | 3,284.60% | 2,996.95% |
Selling, General and Administrative Expense of Revenue |
883.73% | 0.00% | 0.00% | 2,128.57% | 0.00% | 3,177.00% | 3,366.85% | 4,267.41% | 3,333.98% | 2,978.64% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 |
Share Based Compensation of Revenue |
0.00% | — | — | 438.42% | 0.00% | 117.39% | 216.37% | 19.56% | 0.00% | 881.00% |
Graham Net Nets |
0.00 | — | — | 0.00 | — | 0.66 | 1.46 | 1.31 | 1.44 | 2.14 |
Graham Number |
0.00 | — | — | 0.46 | — | 222.90 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.04%) | — | — | (0.25%) | — | 28.76% | (55.71%) | (78.86%) | (137.01%) | (158.75%) |
Free Cash Flow Yield |
(0.25%) | — | — | (0.19%) | — | (16.78%) | (49.84%) | (68.85%) | (116.98%) | (163.47%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.56 | 0.47 | 0.35 | 0.29 | 0.13 |
Operating CF per Share |
0.00 | (0.09) | 0.08 | (0.51) | (0.26) | (17.99) | (22.95) | (15.70) | (15.62) | (8.34) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (1.03) |
Free Cash Flow per Share |
0.00 | (0.09) | 0.08 | (0.51) | (0.26) | (17.99) | (22.95) | (15.70) | (15.62) | (9.37) |
Cash per Share |
0.00 | 0.48 | 0.17 | 0.08 | 0.26 | 81.02 | 74.61 | 37.32 | 28.84 | 12.27 |
Shareholders Equity per Share |
0.00 | 0.36 | 0.12 | (0.01) | 0.29 | 71.58 | 67.85 | 30.07 | 20.51 | 11.28 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.36 | 0.12 | (0.01) | 0.29 | 71.58 | 67.85 | 30.07 | 20.51 | 11.28 |
Free Cash Flow |
(0.14) | (0.28) | 0.27 | (0.79) | (1.16) | (2.28) | (3.50) | (3.22) | (3.83) | (5.24) |
Working Capital |
1.25 | 1.60 | 0.58 | 0.38 | 1.29 | 9.91 | 11.14 | 6.91 | 5.46 | 6.74 |
Capital Expenditures |
— | — | — | — | — | — | — | — | — | (0.57) |
Net Current Asset Value |
0.85 | 1.20 | 0.18 | (0.02) | 1.28 | 8.97 | 10.27 | 6.11 | 4.73 | 6.09 |
EV/EBIT |
0.00 | — | — | 0.00 | — | 0.00 | 1.20 | 0.77 | 0.81 | 0.94 |
Capex to Sales |
0.00 | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 7.97 |
Net Profit Margin |
(2,234.94%) | 0.00% | 0.00% | (2,495.81%) | 0.00% | 3,505.89% | (5,421.08%) | (5,132.73%) | (6,092.79%) | (5,863.66%) |
Price to Operating Income |
0.00 | — | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(6.97%) | (10.10%) | 27.41% | (496.13%) | (47.65%) | (11.79%) | (16.11%) | (23.29%) | (31.65%) | (35.41%) |
Accounts Receivable Turnover |
0.00 | — | — | 0.31 | 0.00 | 0.00 | 1.61 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
— | 0.00 | 0.55 | 0.68 | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | 0.04 |
Inventory Turnover |
— | — | 0.00 | 0.30 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 530.91 | 731.33 | 0.00 | 30,506.70 | 22,919.48 | 44,271.98 | 99,676.47 | 4,763.13 |
Days of Inventory on Hand |
— | — | 559.94 | 2,083.43 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | 0.13 | 0.11 | — | 0.04 | — | — | — |
Average Payables |
— | 0.05 | 0.03 | 0.04 | 0.09 | 0.27 | 0.39 | 0.53 | 1.14 | 1.08 |
Average Inventory |
— | — | — | 0.09 | — | — | — | — | — | — |
Average Assets |
0.65 | 1.47 | 1.25 | 0.67 | 0.96 | 5.96 | 11.07 | 9.69 | 7.58 | 7.51 |
Average Common Equity |
— | 1.02 | 0.81 | 0.19 | 0.63 | 5.17 | 9.70 | 8.26 | 5.61 | 5.67 |
Columns are period end dates